Knowledge Distillery

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…

Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S) protein receptor-binding domain and block virus interactions…

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis. The authors of this article developed a medium-throughput drug screening…

COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after SARS in 2003 and MERS since 2012.

COVID-19 affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is unclear. The objective …

Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes.

There is evidence of central nervous system impairments associated with COVID-19 infection, including encephalopathy.

The objective of this article was to assess clinical outcomes with convalescent plasma treatment vs placebo or standard of care in peer-reviewed and…

SARS-CoV-2 lineage B.1.1.7, a variant first detected in the UK in September 2020, has spread to multiple countries worldwide.

Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19, but evidence from community…

Self-report data on mental distress indicate a deterioration of population mental health in many countries during the COVID-19 pandemic.

The efficacy of interleukin-6 receptor antagonists in critically ill patients with COVID-19 is unclear. In this article the authors evaluated…